DUBAI, United Arab Emirates, May 26, 2020 (GLOBE NEWSWIRE) -- As COVID-19 keeps on destroying all over the globe, researchers are dashing to create cures for the new coronavirus, which started contaminating people toward the end of last year. Researchers and specialists are investigating different roads to think of clinical medicines that can battle the novel coronavirus. One such treatment that is in concentrate currently is Convalescent Plasma Therapy. After China and the US, India has given a thumbs up for confining a convention to lead a clinical preliminary for healing plasma treatment. The treatment has been utilized tentatively before, thus has become a beam of expectation in the battle against the novel coronavirus pandemic.
A most recent review on Global Plasma Therapy Market is led covering different associations of the business from various topographies to think of 100+ pages report. The examination is an ideal blend of subjective and quantitative data featuring key market improvements, challenges that industry and rivalry is looking at, alongside whole investigations and new open door accessible and may slant in Plasma Therapy showcase. The report connects the authentic information from 2013 to 2018 and anticipated until 2027*. Some of the key and developing players that are a piece of inclusion and have being profiled are DePuy Synthes Companies, Grifols, Kedrion Biopharma, Octapharma, Stryker, Baxter International Inc., Terumo BCT, Biotest AG, Arthrex among others.
Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-plasma-therapy-market
Market Analysis: Global Plasma Therapy Market
Global Plasma Therapy Market is registering a healthy CAGR of 15.7% in the forecast period of 2019-2026. This rise in the market value can be attributed to the growth in the use of platelet-rich plasma for the treatment of various diseases that drives the growth of the industry and increasing incidents of sports injuries.
Market Definition: Global Plasma Therapy Market
Blood plasma involves soft tissue healing autologous platelets, platelets and cytokines. It remains a standard method broadly used in specialties of orthopedics, dentistry, and dermatology. Plasma therapy is commonly used in wound healing, facial rejuvenation, and androgenetic alopecia. Plasma is focused on the physiological value up to three to five times and then vaccinated into the tissues.
Key Market Competitors:
Some of the major market competitors currently working in the global plasma therapy market are Arthrex, Inc., Bio Products Laboratory Limited., Takeda Pharmaceutical Company, Biotest AG., Cambryn Biologics LLC, China Biologic Products Holdings Inc., CSL Limited, DePuy Synthes Companies, Grifols, S.A., Kedrion Biopharma S.p.A., Octapharma, Regen Lab SA, Stryker, Telecris Industria e Comercio Ltda., Baxter International Inc., Japanese Red Cross Society, Sanquin Oy, LFB SA, Terumo BCT, INC., Chengdu Institute of Biology (CIB) among others.
Global Plasma Therapy Market By Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others), End User (Hospitals & Clinics, Research Institutions), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) - Industry Trends and Forecast to 2026
Access Full Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-plasma-therapy-market
The Plasma Therapy Market report provides insights on the following pointers:
- Learn about the market strategies that are being adopted by your competitors and leading organizations
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market
- To gain insightful analyses of the market and have a comprehensive understanding of the “Plasma Therapy Market” and its commercial landscape
- Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the Plasma Therapy Market
- To understand the future outlook and prospects for Plasma Therapy Market analysis and forecast.
Market Drivers
- Surging orthopedic diseases and sports injuries including arthritis, fosters the growth of the market
- Growing demand for the usage of platelet-rich plasma for the treatment of numerous diseases, drives the growth of the market
- Government initiatives for the development of plasma derived medicine, is the factor that drives the market growth
- Rising awareness regarding the importance of blood donation, is the key drivers for this market
- Increasing diseases including tetanus, rabies and hepatitis A&B is estimated to impact the market positively
- The cost associated with plasma therapy is quite high, which is likely to impede the market growth
- Absence of responsiveness regarding platelet-rich therapy, hinders the growth of the market
- Absence of compensation policies and strict regulatory policies, restraint the global market growth
Buy this Report (Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries) @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-plasma-therapy-market
Table of Contents-Snapshot
– Executive Summary
Chapter 1 Industry Overview
Chapter 2 Industry Competition by Manufacturers
Chapter 3 Industry Production Market Share by Regions
Chapter 4 Industry Consumption by Regions
Chapter 5 Industry Production, Revenue, Price Trend by Type
Chapter 6 Industry Analysis by Applications
Chapter 7 Company Profiles and Key Figures in Industry Business
Chapter 8 Industry Manufacturing Cost Analysis
Chapter 9 Marketing Channel, Distributors and Customers
Chapter 10 Market Dynamics
Chapter 11 Industry Forecast
Chapter 12 Research Findings and Conclusion
Chapter 13 Methodology and Data Source
For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-plasma-therapy-market
Key Developments in the Market:
- In July 2019, Baxter International Inc. launched PrisMax in the U.S. for maximizing care for Critically Ill Patients. PrisMax is used to treat acute kidney injury (AKI) patients. Every year in the U.S., there are about five million AKI patients, and rates of AKI have been rising. This launch will benefit the company to increase its revenue.
- In June 2018, LabCorp has been approved by the U.S. FDA to market a diagnostic test which will detect viruses in donated blood plasma utilized in preparing biological therapies. This technology provides a diversified alternative for the global biopharmaceutical sector to enhance plasma donor collection programs and the production of plasma protein therapies for a number of life-threatening conditions such as immune, cardio / pulmonary, bleeding, and neurological illnesses. This allowance by the FDA to LabCorp will help the company in market growth and further expansion of the laboratory.
Competitive Analysis:
The global plasma therapy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of plasma therapy market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
COVID-19 Impact on Plasma Therapy Industry
Coronavirus is a large family of viruses known for diseases ranging from the common cold to even more serious diseases such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The virus has spread to almost all regions of the world, affecting both developed and developing countries which have heavily affected pharmaceutical and biotechnology companies. The epidemic spread rapidly across the globe within three months and was characterized by the WHO as a pandemic on March 11, 2020. According to the Worldometers.info, statistics, as of 27th April 2020, 3,064,225 people are already affected and 211,537 patients are dead due to the coronavirus. There are currently no approved specific antiviral agents targeting the new virus, while some drugs are still under investigation, including remdesivir and lopinavir / ritonavir. It is urgent to look for an alternative strategy to treat COVID-19, especially among severe patients, as an effective vaccine and specific antiviral medicines are not available until the date. https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impact-on-plasma-therapy
Browse Related Reports
Global Cold Plasma Market, By Regime Type (Low Pressure, Atmospheric Pressure), Technology (Remote Treatment Direct Treatment, Electrode Contact), Industry (Textile, Polymer And Plastic, Electronics And Semiconductor, Food & Agriculture, Medical), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027 https://www.databridgemarketresearch.com/reports/global-cold-plasma-market
Global Plasma Fractionation Market By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Other Applications), End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-plasma-fractionational-market
Global Mycoplasma Testing Market, By Technique (PCR, ELISA, Direct Assays, Indirect Assays, DNA Staining, Microbial Culture Techniques, Enzymatic), Product (Kits & Reagent, Instruments, Others), Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing, Other), End Users (Hospitals and Surgical Centers, Clinics, Community Healthcare, Others), Distribution Channel (Retail, Direct Tenders), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027 https://www.databridgemarketresearch.com/reports/global-mycoplasma-testing-market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475